Jim Simons Renaissance Technologies
Jim Simons is the founder of Renaissance Technologies, one of the most successful quantitative hedge funds in the world. Before his career in finance, he served as a mathematics professor and made significant contributions to differential geometry. Simons applied his analytical expertise to develop sophisticated, algorithm-driven trading strategies, earning consistently high returns for investors.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Adobe
ADBE
|
+$649M |
| 2 |
Nike
NKE
|
+$453M |
| 3 |
Tesla
TSLA
|
+$431M |
| 4 |
AstraZeneca
AZN
|
+$389M |
| 5 |
Coca-Cola
KO
|
+$336M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Amazon
AMZN
|
+$897M |
| 2 |
ALXN
Alexion Pharmaceuticals
ALXN
|
+$578M |
| 3 |
Moderna
MRNA
|
+$438M |
| 4 |
Apple
AAPL
|
+$417M |
| 5 |
Aon
AON
|
+$386M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 20.55% |
| 2 | Technology | 20.49% |
| 3 | Consumer Staples | 11.15% |
| 4 | Consumer Discretionary | 9.9% |
| 5 | Industrials | 8.51% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
SILK
1851
DELISTED
Silk Road Medical, Inc. Common Stock
SILK
| $2.78M | ﹤0.01% |
50,492
+13,092
| +35% | +$685K |
|
1852
WisdomTree India Earnings Fund ETF
EPI
$2.03B
| $2.77M | ﹤0.01% |
74,100
-50,000
| -40% | -$1.78M |
|
|
ACCD
1853
DELISTED
Accolade Inc
ACCD
| $2.77M | ﹤0.01% |
+65,700
| New | +$3.09M |
|
|
HMNF
1854
DELISTED
HMN Financial Inc
HMNF
| $2.76M | ﹤0.01% |
118,725
+1,800
| +2% | +$41K |
|
1855
Ampco-Pittsburgh
AP
$194M
| $2.76M | ﹤0.01% |
587,001
+17,300
| +3% | +$92.4K |
|
|
LITS
1856
Lite Strategy Inc
LITS
$30.2M
| $2.76M | ﹤0.01% |
49,939
-8,065
| -14% | -$444K |
|
1857
Green Plains
GPRE
$1.09B
| $2.75M | ﹤0.01% |
84,342
-250,501
| -75% | -$8.59M |
|
1858
iShares Expanded Tech-Software Sector ETF
IGV
$14.9B
| $2.75M | ﹤0.01% |
34,500
+18,000
| +109% | +$1.47M |
|
1859
Sonida Senior Living
SNDA
$1.88B
| $2.75M | ﹤0.01% |
78,191
-14,000
| -15% | -$500K |
|
|
AIV
1860
Aimco
AIV
$383M
| $2.75M | ﹤0.01% |
401,940
-913,000
| -69% | -$6.28M |
|
1861
Hyster-Yale Materials Handling
HY
$618M
| $2.75M | ﹤0.01% |
54,700
+9,300
| +20% | +$572K |
|
1862
Akebia Therapeutics
AKBA
$242M
| $2.74M | ﹤0.01% |
949,927
-877,803
| -48% | -$2.51M |
|
|
CCRN
1863
DELISTED
Cross Country Healthcare
CCRN
| $2.73M | ﹤0.01% |
128,618
-63,161
| -33% | -$1.18M |
|
|
LUMO
1864
DELISTED
Lumos Pharma, Inc. Common Stock
LUMO
| $2.72M | ﹤0.01% |
286,412
-19,345
| -6% | -$182K |
|
1865
National Health Investors
NHI
$3.58B
| $2.72M | ﹤0.01% |
50,900
-1,000
| -2% | -$62.5K |
|
|
UXIN
1866
Uxin Ltd
UXIN
$260M
| $2.72M | ﹤0.01% |
9,861
-10,733
| -52% | -$3.54M |
|
1867
Stride
LRN
$3.46B
| $2.71M | ﹤0.01% |
75,300
-107,596
| -59% | -$3.53M |
|
|
RVLP
1868
DELISTED
RVL Pharmaceuticals plc Ordinary Shares
RVLP
| $2.71M | ﹤0.01% |
917,049
-56,053
| -6% | -$188K |
|
1869
Liberty Media Series C
FWONK
$26B
| $2.7M | ﹤0.01% |
54,382
-146,248
| -73% | -$6.92M |
|
1870
Olema Pharmaceuticals
OLMA
$930M
| $2.7M | ﹤0.01% |
+97,900
| New | +$2.64M |
|
1871
Wingstop
WING
$3.44B
| $2.69M | ﹤0.01% |
16,410
-49,200
| -75% | -$8.34M |
|
1872
UMB Financial
UMBF
$11.5B
| $2.69M | ﹤0.01% |
+27,800
| New | +$2.54M |
|
1873
Coca-Cola Consolidated
COKE
$12.6B
| $2.68M | ﹤0.01% |
68,000
+2,000
| +3% | +$79.6K |
|
|
LKFT
1874
Lakefront Biotherapeutics American Depositary Shares
LKFT
$1.8B
| $2.68M | ﹤0.01% |
50,900
+40,700
| +399% | +$2.42M |
|
|
IMBI
1875
DELISTED
iMedia Brands, Inc. Class A Common Stock
IMBI
| $2.67M | ﹤0.01% |
464,358
-135,400
| -23% | -$869K |
|
Similar funds
Jim Simons's Q3 2021 Portfolio in Review
As of Q3 2021, Jim Simons held 4,070 positions worth $77.4B, down 3.3% from $80.1B the previous quarter. Its ten largest holdings account for 12% of the portfolio.
Jim Simons's Q3 2021 filing shows 663 new, 931 increased, 1,797 reduced and 653 closed positions. Its largest new stake was Adobe: 1,030,433 shares worth $593M. The largest sale was Amazon, an estimated $897M.
By sector, the portfolio is most concentrated in Healthcare at 21% of assets, up from 20% a quarter earlier, followed by Technology and Consumer Staples.
- Jim Simons's largest Q3 2021 buy was Adobe: 1,030,433 shares worth $593M.
- Jim Simons added most to Nike in Q3 2021, an estimated $453M increase.
- Jim Simons's biggest Q3 2021 reduction was Moderna, cutting an estimated $438M.
- Jim Simons fully exited Amazon in Q3 2021, selling an estimated $897M.
- Jim Simons's ten largest holdings make up 12% of its $77.4B portfolio in Q3 2021.
- Jim Simons opened 663 new positions and closed 653 in Q3 2021.
- Jim Simons's portfolio value fell 3.3% quarter-over-quarter to $77.4B.
Based on Renaissance Technologies's 13F filing for Q3 2021, filed 12 Nov 2021.